Conference Paper (36)
2008
Conference Paper
25, pp. 133 - 138 (Eds. Braunschweig, B.; Joulia, X.). 18th European Symposium on Computer Aided Process Engineering - ESCAPE, Lyon, France, June 01, 2008 - June 04, 2008. (2008)
Population balance modeling of influenza virus replication in MDCK cells during vaccine production. In: 18th European Symposium on Computer Aided Process Engineering: ESCAPE 18, Vol. 2007
Conference Paper
Closed loop control of perfusion systems in high-density cell culture. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 549 - 551 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
Conference Paper
Serum-free influenza vaccine production with MDCK cells in wave-bioreactor and 5L-stirred tank bioreactor. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 563 - 565 (Ed. Smith, R.). 19th ESACT Meeting , Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
Conference Paper
Influenza Vaccines: Challenges in Mammalian Cell Culture Technology. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 503 - 508 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
Conference Paper
Cultivation of E-FL in Perfusion Mode Using Wave Bioreactor and Stirre-Tank Reactor for Parvovirus Vaccine Production. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 519 - 522 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - June 08, 2005. Springer, Dordrecht, The Netherlands (2007)
Conference Paper
Strategies for Large Scale Production of Parapoxvirus Ovis NZ-2. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 707 - 710 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - August 06, 2005. Springer, Dordrecht, The Netherlands (2007)
Conference Paper
7, pp. 191 - 208. Ringberg-Symposium, Kreuth, Germany, May 03, 2006 - May 05, 2006. (2007)
Biological Fundamentals, Models and Technologies for Vaccine Production. In: Perspectives of Research - Identification and Implementation of Research Topics by Organizations: Ringberg-Symposium Mai 2006, Vol.
Conference Paper
Monitoring of Cell Physiology in Influenza Vaccine Production by Flow Cytometry. In: Cell Technology for Cell Products: Proceedings of the 19th ESACT Meeting, pp. 531 - 533 (Ed. Smith, R.). 19th ESACT Meeting, Harrogate, UK, June 05, 2005 - August 06, 2005. Springer, Dordrecht, The Netherlands (2007)
2005
Conference Paper
Glutamine-free media for vaccine production processes. In: Animal Cell Technology meets Genomics: Proceedings ot the 18th ESACT Meeting, pp. 767 - 770 (Eds. Godia, F.; Fussenegger, M.). 18th ESACT Meeting , Granada, Spain, May 11, 2003 - May 14, 2003. (2005)
Conference Paper
Serum free cultivation of primary chicken embryo fibroblasts in microcarrier systems for vaccine production. In: Animal Cell Technology Meets Genomics: Proceedings of the 18th ESACT Meeting, pp. 771 - 774. 18th ESACT Meeting, Granada, Spain, May 11, 2003 - May 14, 2003. (2005)
2003
Conference Paper
Animal cell cultures for the production of viral vaccines. In: GVC/DECHEMA Vortrags- und Diskussiontagung "Zellkulturen: vom biologischen System zum Produktionsprozess", pp. 32 - 35. GVC/DECHEMA : Vortrags- und Diskussionstagung, Bad Dürkheim, Deutschland, May 26, 2003 - May 28, 2003. (2003)
2001
Conference Paper
Development of bioprocess concepts on vaccine production: influenza virus as an example. In: Animal cell technology: from target to market, pp. 344 - 346 (Eds. Lindner-Olsson, E.; Chatzissavidou, N.; Luellau, E.). 17th ESACT Meeting, Tylösand, Sweden, June 10, 2001 - June 14, 2001. (2001)
Meeting Abstract (58)
2023
Meeting Abstract
53 (2) Special Issue: SI Ed., P339. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), September 26, 2023 - September 29, 2023. Wiley-VCH, Weinheim (2023)
Characterization of the local innate immune response after mucosal application of IAV Defective Interfering Particles. In European Journal of Immunology,
Meeting Abstract
107 (10), p. 177 - 177. IPITA-IXA-CTRMA 2023 Joint Congress, San Diego, USA, October 26, 2023 - October 29, 2023. Lippincott Williams & Wilkins, Baltimore (2023)
Genetic knockout of porcine GGTA1 or CMAH/GGTA1 is associated with the emergence of neo-glycans. In Transplantation,
Meeting Abstract
53 (2) Special Issue: SI Ed., P376. Joint Conference of the Société Française d'Immunologie (SFI) and the Deutsche Gesellschaft für Immunologie (DGfI), Strasbourg (France), September 26, 2023. Wiley-VCH, Weinheim (2023)
Adjuvanted SARS-CoV-2 spike protein vaccination with altered glycosylation elicits improved TH1 humoral and cellular immunity in mice. In European Journal of Immunology, 2022
Meeting Abstract
Producing viruses in orbit: Current developments for orbital shaken viral vaccine manufacturing. In Proceedings Vaccine Technology VIII, 54. Vaccine Technology VIII, Sitges (Spain), June 12, 2022 - June 17, 2022. (2022)
Meeting Abstract
Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processes. In Proceedings Vaccine Technology VIII, 60. Vaccine Technology VIII, Sitges (Spain), June 12, 2022 - June 17, 2022. (2022)
Meeting Abstract
Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus production. In Proceedings Single-Use Technologies V: Building the Future, 40. Single-Use Technologies V: Building the Future, Marseille, France, March 20, 2022 - March 23, 2022. (2022)
Meeting Abstract
SARS-COV-2 production in a single-use scalable high cell density bioreactor. In Proceedings Single-Use Technologies V: Building the Future, 29. Single-Use Technologies V: Building the Future, Marseille, France, March 20, 2022 - March 23, 2022. (2022)
Meeting Abstract
Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr®15 microbioreactors. In Proceedings Vaccine Technology VIII, 55. Vaccine Technology VIII, Sitges (Spain), June 12, 2022 - June 17, 2022. (2022)
2021
Meeting Abstract
31 12 Ed., P145, p. 1745 - 1745. 2021 Annual Meeting of the Society for Glycobiology, San Diego, California, USA, November 07, 2021 - November 10, 2021. Oxford University Press, Oxford (2021)
CDG-IIb syndrome: Clinical phenotype and in-depth glycomic characterization of a novel patient. In Glycobiology, 2020
Meeting Abstract
Droplet-based microfluidics for bottom-up synthetic biology. In 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences (MicroTAS 2019), pp. 14 - 15. 23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, Basel, Switzerland, October 27, 2019 - October 31, 2019. Curran Associates, Red Hook NY USA (2020)
2019
Meeting Abstract
Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidates. In Integrated Continuous Biomanufacturing IV, 76. Biomanufact IV, Ocean Edge Resort Brewster (Cape Cod), Massachusetts, USA , October 06, 2019 - October 10, 2019. (2019)
Meeting Abstract
A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccines. In Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92. Advancing Manufacture of Cell and Gene Therapies VI, Loews Coronado Bay Hotel Coronado, California, USA, January 27, 2019 - January 31, 2019. (2019)
Meeting Abstract
258, 45-ENFL. ACS Fall National Meeting and Exposition, San Diego, CA, August 25, 2019 - August 29, 2019. (2019)
High-pressure methane adsorption and characterization of pores in Posidonia shales and isolated kerogens. In Abstracts of Papers of the American Chemical Society, 2018
Meeting Abstract
Highly efficient influenza virus production: A MDCK-based high-cell-density process. In Vaccine Technology VII, 13. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Orbital shaken bioreactor for influenza A virus production in high cell density cultivations. In Vaccine Technology VII, 40. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatography. In Vaccine Technology VII, 124. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine viruses. In Vaccine Technology VII, 48. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapy. In Vaccine Technology VII, 133. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidates. In Vaccine Technology VII, 128. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Flavivirus production in perfusion processes using the EB66® cell line. In Vaccine Technology VII, 80. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Addressing the challenges of influenza virus-like particles purification. In Vaccine Technology VII, 57. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
28 12 Ed., 144, pp. 1057 - 1058. Annual Meeting of the Society-for-Glycobiology (SFG), New Orleans, LA (USA), November 05, 2018 - November 08, 2018. (2018)
CGE-LIF as a novel approach for the analysis of glycosphingolipid-derived glycans. In GLYCOBIOLOGY,
Meeting Abstract
Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactions. In Vaccine Technology VII, 75. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
Meeting Abstract
Efficient influenza vaccine manufacturing: Single MDCK suspension cells in chemically defined medium. In Vaccine Technology VII, 5. Vaccine Technology VII, Mont Tremblant, Canada, June 17, 2018 - June 22, 2018. (2018)
2017
Meeting Abstract
Stirred tanks in cascades and plug-flow tubular bioreactors for continuous production of viral vaccines. In ECI Symposium Series. Integrated Continuous Biomanufacturing III, Cascais, Portugal, September 17, 2017 - September 21, 2017. (2017)
2016
Meeting Abstract
Pseudo-affinity purification and formulation of a cell-culture derived whole influenza virus vaccine using magnetic sulfated cellulose particles. In Vaccine Technology VI, 57. Vaccine Technology VI, Albufeira, Portugal, June 12, 2016 - June 17, 2016. (2016)
2015
Meeting Abstract
32 (5), p. 321 - 321. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
IgCarbKB: a glycomics and glycoproteomics focused immunoglobulin knowledge base. In Glycoconjugate Journal,
Meeting Abstract
32 (5), p. 206 - 206. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Unraveling The N-glycosylation Of Induced Pluripotent Stem Cells From A PMM2-CDG Patient. In Glycoconjugate Journal,
Meeting Abstract
32 (5), p. 293 - 293. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
The Sweet Side of Neurons–xCGE-LIF Based Structural Characterization of Neuron and Synaptic N-GlycansComposition. In Glycoconjugate Journal,
Meeting Abstract
Human blood plasma O-glycoproteomics. In Glycoconjugate Journal, (5), pp. 324 - 325. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Meeting Abstract
32 (5), p. 290 - 290. GLYCO 23 XXIII International Symposium on Glycoconjugates, Split, Kroatien, September 15, 2015 - September 20, 2015. (2015)
Region-specific N-glycan mapping in inflammatory bowel disease and control tissue using PGC-LC-ESI-MS/MS. In Glycoconjugate Journal, 2014
Meeting Abstract
31 Supplement, p. S180. (2014)
The impact of MDCK cell source on the production of influenza and canine adenovirus. In New Biotechnology: Abstracts of the 16th European Congress on Biotechnology,
Meeting Abstract
Functional characterization of PMM2-CDG patient-derived iPSCs. In GLYCOBIOLOGY, (11) 24 Ed., p. 1101 - 1101. (2014)
Meeting Abstract
24 11 Ed., p. 1101 - 1101. Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, Hawaii, USA, November 16, 2014 - November 19, 2014. IRL Press at Oxford University Press, Oxford (2014)
Functional characterization of PMM2-CDG patient-derived iPSCs. In Glycobiology,
Meeting Abstract
24 11 Ed., pp. 1176 - 1177. Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, Hawaii, USA, November 16, 2014 - November 19, 2014. IRL Press at Oxford University Press, Oxford (2014)
Molecular characterization of hiPSCs from a PMM2-CDG patient revealed aberrant glycosylation. In Glycobiology,
Meeting Abstract
24 11 Ed., p. 1160 - 1160. Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, Hawaii, USA, November 16, 2014 - November 19, 2014. IRL Press at Oxford University Press, Oxford (2014)
Comparative performance of four methods for high-throughput glycosylation analysis of immunoglobulin G in genetic and epidemiological research. In Glycobiology, 2011
Meeting Abstract
5 (S8), P47. 22nd European Society for Animal Cell Technology (ESACT) - Meeting on Cell Based Technologies
, Vienna, Austria, May 15, 2011 - May 18, 2011. (2011)
Criteria for bioreactor comparison and operation standardisation during process development for mammalian cell culture. In BMC Proceedings,
Meeting Abstract
28 (5 ), 332. 21st International Symposium on Glycoconjugates - Glyco 21, Wien, Östereich, August 21, 2011 - August 26, 2011. (2011)
Tailored methods for CGE-LIF based multiplexed high-throughput glycoanalysis with respect to sample characteristics. In Glycoconjugate Journal,